JAKKS Pacific Inc. Common Stock (JAKK)
Slow GrowerFairStock Score: 46/100 — MIXED
Key Financials
| Current Price | $21.32 |
| Market Cap | $261M |
| P/E Ratio | 30.46 |
| ROE | 3.34% |
| Dividend Yield | 4.62% |
| Sector | Consumer Cyclical |
Strengths
- Conservative balance sheet with debt-to-equity of just 0.21, providing financial flexibility
- Attractive 4.4% dividend yield providing steady income returns
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 2.8% year-over-year signals potential demand weakness or market share loss
- Weak Piotroski F-Score of 3/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of 1.2 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
JAKKS Pacific Inc. Common Stock is a micro-cap consumer cyclical company valued at $261 million. Revenue stands at $571 million, though the company is currently unprofitable. From a quality standpoint, JAKKS shows weak Piotroski F-Score of 3/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.2 warrants caution. On valuation, the stock is trading at a premium 26.3x earnings, with trades above its Graham Number with a negative 11% margin. Growth dynamics show revenue growing at -2.8% and profit growth of 41.6%. The 4.4% dividend yield adds an income component for patient holders. Our composite FairStock Score of 46/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer